Review
Open access
Aug 2026
Clinical applications of selected liquid biopsy biomarkers in pancreatic cancer with a focus on ctDNA CTCs and exosome derived biomarkers
Pancreatic ductal adenocarcinoma (PDAC) remains a major clinical challenge because reliable biomarkers for early detection, risk stratification, and treatment monitoring are still limited. Liquid biopsy has emerged as a promising complementary approach that enables minimally invasive assessment of tumor-derived materia...
Lin Mi, Yan-Xiong Wang, Hai-Bo Xu et al.
· Discover Oncology · 0 citations